Abstract
The effects of antagonists and agonists of the platelet-activating factor (PAF) receptor on the formation of long-term potentiation (LTP) were examined in slices of rat hippocampus. The antagonist rans-BTD (rans-2,5-bis-(3,4,5-trimethoxyphenyl)-1,3-dioxolane) at concentrations of 8 - 16 microM blocked LTP in field CA1 while the same concentration of a stereo isomer (cis-BTD) with low affinity for PAF receptors was without effect. CV3988, an antagonist structurally related to PAF, also attenuated LTP. The blockade of LTP by trans-BTD was partially reversed by simultaneous application of the non-metabolizable receptor agonist carbamyl-PAF. Trans-BTD did not change the following physiological measures: (i) paired-pulse facilitation, (ii) responses occurring during the short bursts given to induce LTP, (iii) N-methyl-d-aspartate receptor-mediated responses, and (iv) potentiation measured during the first minute after high-frequency stimulation. It thus appears that trans-BTD interferes with LTP at some step after induction and initial expression. These results suggest that activation of PAF receptors contributes to the stabilization of LTP, possibly via an effect on intracellular calcium levels.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
